Market News & Trends
Access Pharmaceuticals Announces Global Plasma Therapeutics License
Access Pharmaceuticals has signed an exclusive global license agreement with Plasma Technologies LLC for the development and commercialization of its proprietary plasma fractionation process. Concurrently,…
Abcam & Children’s Cancer Institute Enter Exclusive Agreement
Children’s Cancer Institute and Abcam plc recently announced they have entered into an exclusive licence, supply and distribution agreement for multidrug resistance protein 4 (MRP4/ABCC4)…
SGS Announces Completion of New Lab in CA
SGS Life Science Services recently announced the completion of its fifth North American Life Science Services laboratory, in Carson, California. The new, 8,000-sq-ft GMP/GLP facility…
Daiichi Sankyo to Acquire Ambit Biosciences
Daiichi Sankyo Company, Ltd. and Ambit Biosciences jointly announced they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of…
Global Market for Cancer Profiling Technologies to Reach Nearly $54.8 Billion
The global healthcare industry is seeing new developments, improved point-of-care diagnostics, cost-effective treatment modalities, and advances in personalized medicine, which not only offer efficient early…
Implementing Innovations in Injectable Drug Delivery With the User & Pharmaceutical Manufacturer in Mind
By: John A. Merhige, Chief Commercial Officer, and Dan Thayer, Technology Director, Credence MedSystems, Inc. The Current Climate Change is hard. This is true in…
TapImmune Releases Positive Interim Data for Ovarian & Breast Cancer
TapImmune Inc. is extremely pleased to report that analysis of the interim data from the first 13 patients in a Phase I clinical trial show…
Relmada Therapeutics Enters Agreement With Memorial Sloan Kettering
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, recently announced it has entered into an agreement with Memorial…
Medimetrics Expands Medical Device Portfolio
Medtech innovator Medimetrics continues its expansion into the global medical devices sector with official recognition of its full design and product development capabilities and the…
Foster Delivery Science to Build New Facility; Supports Increased Demand
Foster Delivery Science has recently broken ground on a new facility to support increased demand for manufacturing drug delivery and implant polymer blends. The facility…
Cubist Announces Continued Global Expansion Opens International Headquarters
With resistant bacterial infections resulting in an estimated 25,000 deaths in the European Union and 23,000 deaths in the United States annually, the issues of…
Boehringer Ingelheim & CureVac Announce Major Development Collaboration
Boehringer Ingelheim and CureVac recently announced an exclusive global license and development collaboration. The new collaboration focuses on CureVac’s CV9202, a novel investigational therapeutic mRNA…
Asia-Pacific’s Glioblastoma Multiforme Treatment Market Value to More Than Double by 2020
Asia-Pacific’s Glioblastoma Multiforme Treatment Market Value to More Than Double by 2020 The Glioblastoma Multiforme (GBM) therapeutics market in Asia-Pacific (APAC) will more than…
Australia’s Pharma Sector to Grow to $32.1 Billion
Australia’s healthcare market is set to grow to an impressive $42.5 billion by 2020, driven by universal healthcare coverage provided by Medicare and good access…
Edge Therapeutics Gets $10 Million From Hercules Technology
Edge Therapeutics recently announced it has obtained up to $10 million in venture debt financing from Hercules Technology Growth Capital, Inc. (HTGC), to support the…
Seattle Genetics & Genmab Enter New Antibody-Drug Conjugate Collaboration
Seattle Genetics, Inc. and Genmab A/S recently announced the companies have entered into an additional antibody-drug conjugate (ADC) collaboration. Under the new agreement, Genmab will…
Aerie Announces $125-Million Commitment
Aerie Pharmaceuticals, Inc. recently announced it has received a $125-million financing commitment from Deerfield Management Company L.P., a current Aerie shareholder. The financing is expected…
Ophthotech Corporation Achieves $50-Million Milestone
Ophthotech Corporation (OPHT) recently announced it has achieved a $50- million enrollment milestone payment from Novartis Pharma AG as part of the ex-US licensing and…
Thrive Bioscience Start-Up Now Open for Business
Thrive Bioscience, Inc., a spinoff of successful Beverly firm, Sage Science, Inc., recently announced it will open its doors at 500 Cummings Center, Suite 3150…
Global Market for Nanoparticles in Biotechnology & Pharmaceuticals to Reach $79.8 Billion
The nanoparticle drug/delivery market presents an increasingly significant part of the overall pharmaceutical product market worldwide. The most rapid advances have been made in drug research…
